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Abstract: The effects of hydroxyapatite (HA)-coating onto collagen carriers for application of
recombinant human bone morphogenetic protein 2 (rhBMP-2) on cell differentiation in vitro, and
on in vivo healing patterns after sinus-augmentation and alveolar socket-grafting were evaluated.
In vitro induction of osteogenic/adipogenic differentiation was compared between the culture
media with rhBMP-2 solution and with the released rhBMP-2 from the control collagen and from the
HA-coated collagen. Demineralized bovine bone and collagen/HA-coated collagen were grafted
with/without rhBMP-2 in sinus-augmentation and tooth-extraction-socket models. Adipogenic
induction by rhBMP-2 released from HA-coated collagen was significantly reduced compared to
collagen. In the sinus-augmentation model, sites that received rhBMP-2 exhibited large amounts
of vascular tissue formation at two weeks and increased adipose tissue formation at eight weeks;
this could be significantly reduced by using HA-coated collagen as a carrier for rhBMP-2. In
extraction-socket grafting, dimensional reduction of alveolar ridge was significantly decreased at
sites received rhBMP-2 compared to control sites, but adipose tissue was increased within the
regenerated socket area. In conclusion, HA-coated collagen carrier for Escherichia coli-derived
rhBMP-2 (ErhBMP-2) may reduce in vitro induction of adipogenic differentiation and in vivo adipose
bone marrow tissue formation in bone tissue engineering by ErhBMP-2.
Keywords: bone morphogenetic protein; collagen; hydroxyapatite; drug delivery system;
bone regeneration
1. Introduction
The clinical applications of recombinant human bone morphogenetic protein (rhBMP-2) have
been studied widely in bone tissue engineering since the development of protein-recombination
technology [1]. Based on the vast amount of scientific evidence available from previous research,
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including in vitro/in vivo preclinical experiments and clinical studies [2–5], clinical use of rhBMP-2
has been approved by the Food and Drug Administration (FDA), although its use is restricted
to limited indications: nonunion of long bones and spinal fusion in the field of orthopedics, and
maxillary sinus and alveolar bone augmentation in the dental field [6–8].
In the field of dentistry, however, several other recent studies have raised questions regarding the
rationale for using rhBMP-2 in sinus augmentation. Although it was expected that rhBMP-2 would
enhance the bone quality in regenerated bone tissue, Kao et al. reported decreased bone quality
in a histologic study (randomized clinical trial) of sinus augmentation with rhBMP-2 compared to
the conventional technique [9]. Some also expected that rhBMP-2 would promote healing processes
in bone regeneration, and reduce time to prosthetic loading. However, a recent preclinical study
using rabbit sinus model revealed limited formation of mineralized tissue in the central area of the
augmentation at sites received bone graft materials accompanied by rhBMP-2 [10]. These findings
suggest that instead of promoting the early bone-healing processes within sinus augmentation,
rhBMP-2 switched the direction of those processes.
Tissue responses to rhBMP-2 may be influenced by the characteristics or environment of
the recipient site, including the type of affected cells, the presence of other growth factors from
adjacent tissues, or the characteristics of the experimental subject. The defect type may also be
an affecting factor. In the aforementioned study [10], the peculiar healing pattern was observed in
a sinus-augmentation model, and it might not be found in other preclinical models such as ectopic
subcutaneous/intramuscular models, long-bone defects, calvarial defects, and other augmentation
models. Other studies suggest that the concentration/dose of applied rhBMP-2 is a critical factor
in reducing the incidence of unwanted effects such as adipose tissue (AT) formation [11] or cystic
changes [12]. The application of rhBMP-2 in tissue engineering enables the concentration of the
protein at the defect site to be significantly higher than would be available in the normal physiologic
state, especially with the initial burst release from the carrier system. Thus, control of the release from
carriers could be a solution for the successful clinical application of rhBMP-2.
One representative rhBMP-2 carrier system is absorbable collagen sponge (ACS), which is
the only carrier with FDA approval, and many other controlled-release carrier systems have been
researched. Hydroxyapatite (HA)-coated collagen was recently introduced in an attempt to improve
the weakness of the ACS carrier system by enabling controlled release and strengthening its
mechanical stability. The aim of this biomaterial was to mimic the physicochemical properties
of bone; it has been suggested that the negatively charged sites of the HA coating interact
electrostatically with the positive charge of the amino acids in BMP-2 [13]. Yang et al. previously
demonstrated the controlled release profile of rhBMP-2 from an HA-coated collagen carrier system
and enhanced osteoinduction by Escherichia coli-derived rhBMP-2 (ErhBMP-2) for calvarial defect
healing compared to conventional carrier of ACS [14]. They also suggested that AT formation in the
early healing processes could be reduced by decreasing the initial availability of rhBMP-2 via the use
of a controlled-release carrier system.
The aim of the present study was to determine whether using HA-coated collagen as a
carrier for rhBMP-2 enhances the bony regeneration in two different types of defects, mimicking
the limited clinical indications for which the FDA has approved its use. The specific objectives
were twofold: (1) to determine the effects of an HA-coated collagen carrying rhBMP-2 on cell
differentiation in vitro; and (2) to determine the in vivo healing pattern in the sinus-augmentation
and alveolar socket-grafting models following implantation of rhBMP-2 with the HA-coated collagen
carrier system.
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2. Materials and Methods
2.1. Preparation of the HA-Coated Collagen Carrier
The HA-coated collagen carrier used in this study was provided by Professor Byung-Soo
Kim from Seoul National University, and was produced with standardized protocol as described
previously [14]. Briefly, commercially available type I ACS (HeliCOTE; Integra Life Sciences, York,
PA, USA) was coated with HA by immersing/incubating in a simulated body fluid (SBF) solution,
comprised reagent-grade NaCl (40.017 g/L), NaHCO3 (1.775 g/L), KCl (1.125 g/L), K2HPO4¨3H2O
(1.155 g/L), MgCl2¨6H2O (1.555 g/L), CaCl2 (1.46 g/L), Na2SO4 (0.36 g/L), and (CH2OH)3CNH2
(30.285 g/L) dissolved in distilled water [15]. The collagen scaffolds were then carefully washed five
times with distilled water, and lyophilized for 1 day. ACS used as a default carrier in all experiments
of this study was same as the one that was used for aforementioned HA-coating protocol.
2.2. In Vitro Assay for Cell Differentiation Induced by the rhBMP-2 Released from Its Carriers
2.2.1. Preincubation in the Cell-Growth Medium
The rhBMP-2 used in this study was provided by the research institute of Cowellmedi (Pusan,
Korea). The rhBMP-2 was expressed in Escherichia coli (ErhBMP-2), as described previously [16].
Four types of cell culture medium were prepared for the experimental groups, according to the type
of carrier and loading (or not) of ErhBMP-2 (n = 3 per group):
‚ Negative control group: standard culture medium.
‚ Positive control group: standard culture medium containing ErhBMP-2 (1 µg/mL).
‚ C/BMP-2 group: standard culture medium in which ErhBMP-2-soaked ACS was placed during the
planned releasing periods, after presoaking with ErhBMP-2 (1 µg/mL) for 30 min. (C: absorbable
collagen sponge)
‚ HA/BMP-2 group: standard culture medium with the same conditions as for the C/BMP-2 group,
except that HA-coated collagen was used as the carrier instead of ACS.
Collagen and HA-coated collagen were cut into standardized circular sheets (3 mm thick and
8 mm in diameter) using a tissue punch. The culture media with ErhBMP-2 solution, rhBMP-2-loaded
ACS, and rhBMP-2-loaded HA-coated collagen were preincubated for 3, 7 and 14 days to allow release
of ErhBMP-2.
2.2.2. Induction of Osteogenic and Adipogenic Differentiation
Cell differentiation (osteogenic and adipogenic) assays were performed to evaluate the
bioactivity of the released ErhBMP-2 at three different releasing periods: determining responses
to differentiative induction of cells stimulated by released ErhBMP-2 in each period. Human
gingival fibroblasts (hGFs) were used for both cell differentiation assays. Gingival tissues from one
patient receiving dental implant treatment were collected and hGFs were isolated. The experimental
protocol was approved by the Ethics Committee of the College of Dentistry, Yonsei University
(IRB No. 2-2010-0032), and written informed consent was obtained before enrollment to the study.
Cells at 4th passage were seeded into six-well plates at a density of 1 ˆ 105 cells/well, and cultured in
each medium for 5 days until they reached subconfluence. The culture medium was then replaced by
the specific culture medium for osteogenic differentiation. After 4 weeks of induction, the cells were
stained with Alizarin Red. For adipogenic differentiation, the cells were subjected to three cycles
of adipogenic induction/maintenance, starting at confluence. Each cycle involved treating the cells
with adipogenic induction medium for 3 days followed by adipogenic maintenance medium for the
next 3 days. The adipogenic differentiation media were purchased from Lonza (Lonza Walkersville,
Walkersville, MD, USA). At the end of 21 days of culture, mature adipocytes were detected by Oil Red
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O staining. The total areas of mineralized nodule formation and lipid vacuoles were measured using
an automated image-analysis system (Image-Pro Plus, Media Cybernetics, Rockville, MD, USA).
2.3. In Vivo Assay for Tissue Regeneration Using Two Types of Animal Model
2.3.1. Experimental Animals
Twenty male New Zealand white rabbits weighing 2.5–3.0 kg were selected for the rabbit
sinus-augmentation model, and five male beagle dogs aged approximately 15 months and weighing
10–15 kg were used for the extraction-socket model. The animal selection, management, surgical
protocol, and preparation were approved by the Institutional Animal Care and Use Committee of
Yonsei Medical Center, Seoul, Korea.
2.3.2. Study Design and Surgical Procedures
The same experimental design of group categorization was applied in both in vivo assays;
however, deproteinized bovine bone mineral (DBBM) was added as a space-maintaining biomaterial
in in vivo experiments for mimicking clinical situations. ACS and HA-coated collagen were minced
into standardized, small pieces (2 mm ˆ 2 mm) and mixed with DBBM at a proportion of 30 pieces of
collagen per 150 mg of DBBM. At sites receiving ErhBMP-2, 30 pieces of both control and HA-coated
collagen were soaked in 0.3 mL of ErhBMP-2 at a concentration of 0.25 mg/mL for 30 min, and then
mixed with 150 mg of DBBM. The control and experimental groups were categorized as follows:
‚ Sham control group: sham surgery sites with no graft (included only in the extraction-socket
grafting experiment).
‚ DBBM group: experimental sites received DBBM only.
‚ DBBM/C group: experimental sites received DBBM and ACS.
‚ DBBM/C/BMP-2 group: experimental sites received DBBM and ErhBMP-2-loaded ACS.
‚ DBBM/HA group: experimental sites received DBBM and HA-coated collagen.
‚ DBBM/HA/BMP-2 group: experimental sites received DBBM and ErhBMP-2-loaded
HA-coated collagen.
Sinus-Augmentation Experiment: Surgical procedures for sinus augmentation were performed
with the protocol as described previously; [10] briefly, bilateral/standardized/circular windows were
prepared on roofs of maxillary sinus using a trephine bur. The trephined bony disk was carefully
removed, and sinus membrane was then elevated. Forty sinuses in twenty rabbits were first divided
into two groups according to the prescribed healing period: 2 and 8 weeks. Twenty sinuses in each
group were assigned randomly to one of the 5 aforementioned experimental groups by randomly
picking a sealed envelope inside which there was predesigned group information (n = 4 in 10 groups
of 5 experimental conditions and 2 observational periods). Sham surgery control group was excluded
in this experiment, due to its impracticality in this model; the space-maintaining grafting biomaterial
(DBBM) is an indispensable factor in sinus augmentation. The prepared mixtures of DBBM (150
mg) with/without control collagen/HA-coated collagen and/or rhBMP-2 were implanted into the
sinuses. The animals were sacrificed after 2 or 8 weeks postoperatively by anesthetic overdose.
Extraction-Socket Grafting Experiment: Unilateral mandibular second, third, and fourth
premolars were hemisectioned, the six roots were gently extracted using a forcep. The sites were
rotationally divided into one control group and five treatment groups for an even distribution (n = 5
in each group), and grafted with mixture of biomaterials up to the ridge crest according to group
allocation. Primary closure was achieved by advancing and suturing the periosteal flaps. After
8 weeks of healing, the dogs were sacrificed by anesthetic overdose.
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2.3.3. Radiographic Analysis Using Micro-Computed Tomographic Images
Block sections including the augmented area and surrounding tissues were cut and fixed in
10% buffered formalin for 10 days. The fixed block specimens were scanned using micro-computed
tomography (SkyScan 1072, SkyScan, Aartselaar, Belgium) at a resolution of 35 mm (100 kV, 100 µA).
The scanned data sets were processed in digital imaging and communications in medicine (DICOM)
format and reconstructed with computer-based software (On-Demand 3D, Cybermed, Seoul, Korea).
In all sectioned planes, the total augmented areas were identified by color coding and traced manually
using the software program, and the overall topography of experimental sites was reconstructed.
Sinus-augmentation experiment: The overall dimensional topography of the rabbit sinuses
and supporting bone was visualized in a reconstructed image. The maximum augmented height
(AH) was measured on the images of coronal sections. Among the serial sections, one image of
each site was chosen by considering the highest peak in the reconstructed view based on linear
measurements. The total augmented volume (AV) was calculated by integrating the color-coded data
from all micro-computed tomographic images.
Extraction-socket grafting experiment: The central-most sagittal plane for each socket site was
superimposed onto the same plane of a pristine tooth in the contralateral mandible, with references
to the inferior and lingual borders of alveolar bone. In a superimposed view, the extraction socket
was divided into three regions of equal size from the crestal-most bony top to the apex of the tooth:
the coronal, middle, and apical regions. Dimensional alterations were calculated by subtracting the
alveolar bone area in experimental sites from that of pristine tooth sites in each region. The vertical
distance was measured from the crestal-most reference line that passed perpendicularly along the
long axis of tooth to the outer surface of resorbed alveolar bone.
2.3.4. Histologic/Histomorphometric Analysis
Specimens were decalcified in 5% formic acid, and embedded in paraffin. Serial sections
(5 µm-thickness) were cut coronally along the center of the augmented sinus and in the buccolingual
plane from the center of the extraction sockets. The two central-most sections were chosen and stained
with Masson’s trichrome. The histologic slides were observed and digitally captured using a light
microscope (BX50, Olympus, Tokyo, Japan). Histomorphometric measurements were made using
a PC-based image-analysis system (Image-Pro Plus, Media Cybernetics). The quality of the grafted
area from each histologic specimen of both experiments was evaluated by quantifying the relative
composition of the total augmented area (%) with respect to newly formed bone (NB), residual
material (RM), adipose tissue (AT), blood vessel (BV), and connective tissue (CT).
2.4. Statistical Analysis
The results of all experiments were analyzed using SPSS software (version 19.0, SPSS, Chicago,
IL, USA). The mean and standard deviation (SD) were calculated, and all data were presented as
mean ˘ SD values. All in vitro experiments were performed in triplicate, and one-way analysis
of variance (ANOVA) was used for comparison between experimental groups with the same
preincubation time. In an in vivo experiment of rabbit sinus augmentation, one-way ANOVA was
used to compare the groups in the same observation period, and unpaired t-test was performed to
analyze the differences between two groups with the same material but different observation periods.
Repeated-measures ANOVA followed by post hoc Scheffé’s comparison was used to analyze the
experimental extraction-socket grafting in dogs. The threshold for statistical significance was set at
p = 0.05.
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3. Results
3.1. In Vitro Cell Differentiation Induced by rhBMP-2 Released from Its Carrier System
Multiple mineralized nodules and lipid vacuoles were observed at all induced sites of the
positive control group and both experimental groups with released rhBMP-2, although negative
control sites preincubated with standard medium also exhibited limited formation of these structures.
The area of mineralized nodules and lipid vacuoles was largest at positive control sites preincubated
with rhBMP-2 solution, uniformly regardless of the preincubation period (Figure 1). The C/BMP-2
and HA/BMP-2 groups exhibited decreased osteogenic and adipogenic induction compared to
the positive control group, but the induction of cell differentiation increased with increasing
preincubation periods (3, 7, and 14 days) and release of ErhBMP-2. There were statistically
significant differences in osteogenic induction between positive control group and HA/BMP-2 group
for all preincubation periods (Figure 1B), but adipogenic induction in the HA/BMP-2 group was
significantly reduced compared to the both positive control and C/BMP-2 groups (Figure 1D).
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Figure  1.  In vitro assay  to explore  the  cell differentiation  induced by  rhBMP‐2  released  from  two 
carrier systems. (A) Mineralized nodules formed after four weeks of osteogenic induction and were 
stained with Alizarin Red  (original magnification ×400,  scale bar = 25  μm);  (B) The  total areas of 
mineralized nodules were morphometrically measured. The area of mineralized nodules was largest 
in positive control group, regardless of the preincubation period. There were statistically significant 
differences  in  the  degree  of  osteogenic  induction  between  the  positive  control  group  and  the 
HA/BMP‐2 group at all preincubation periods (* p < 0.05); (C) Lipid vacuoles were observed by Oil 
Red O staining after four weeks of adipogenic induction (original magnification ×400, scale bar = 25 μm); 
(D) The total areas of  lipid vacuoles were also measured. The degree of adipogenic  induction was 
significantly  lower  in the HA/BMP‐2 group than  in both the positive control and C/BMP‐2 groups  
(* p < 0.05).  (+) Control, Positive control group;  (−) Control, Negative control group; C, absorbable 
collagen sponge; BMP‐2, bone morphogenetic protein‐2; HA, hydroxyapatite‐coated collagen. 
3.2. In Vivo Tissue Regeneration in the Rabbit Sinus‐Augmentation Model 
3.2.1. Radiographic Analysis 
Both experimental sites (DBBM/C/BMP‐2 and DBBM/HA/BMP‐2) exhibited increased AV and 
AH compared to the other three groups (DBBM, DBBM/C, and DBBM/HA) (Figure 2). Regardless of 
the observation period (i.e., two or eight weeks), the AH and AV were significantly greater in both  
rhBMP‐2‐applied groups than in the DBBM group (p < 0.05). Sites that received DBBM and ACS or 
HA‐coated collagen appeared to exhibit a greater AH and AV than sites that received DBBM only, 
which might  be  attributable  to  the  additional  grafted  volume  of  the  collagen.  The  differences, 
however, were not statistically significant. The AH and AV in the DBBM/C/BMP‐2 group decreased 
from two to eight weeks, while conversely, those in all four of the other groups increased over time. 
Interestingly,  coronally  sectioned  views  of  the DBBM/C/BMP‐2  group  specifically  demonstrated 
radiolucent zones within the augmented area, and these radiographic voids also decreased in size 
between two and eight weeks. 
Figure 1. In vitro assay to explore the cell differentiation induced by rhBMP-2 released from two carrier
systems. (A) Mineralized nodules formed after four weeks of osteogenic induction and were stained
with Alizarin Red (original magnification ˆ400, scale bar = 25 µm); (B) The total areas of mineralized
nodules were morphometrically measured. The area of mineralized nodules was largest in positive
control g oup, regardless of the preincubation period. Th re were sta stically significant differences
in the degree of osteogenic indu tion between the ositive control group and the HA/BMP-2 group at
all preincubatio periods (* p < 0.05); (C) Lipid vacuoles were observed by Oil Red O staining after four
weeks of adipogenic induction (original magnification ˆ400, scale bar = 25 µm); (D) The total areas
of lipid vacuoles were also measured. The degree of adipogenic induction was significantly lower in
the HA/BMP-2 group than in both the positive control and C/BMP-2 groups (* p < 0.05). (+) Control,
Positive control group; (´) Control, Negative control group; C, absorbable collagen sponge; BMP-2,
bone morphogenetic protein-2; HA, hydroxyapatite-coated collagen.
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3.2. In Vivo Tissue Regeneration in the Rabbit Sinus-Augmentation Model
3.2.1. Radiographic Analysis
Both experimental sites (DBBM/C/BMP-2 and DBBM/HA/BMP-2) exhibited increased AV and
AH compared to the other three groups (DBBM, DBBM/C, and DBBM/HA) (Figure 2). Regardless
of the observation period (i.e., two or eight weeks), the AH and AV were significantly greater in
both rhBMP-2-applied groups than in the DBBM group (p < 0.05). Sites that received DBBM and
ACS or HA-coated collagen appeared to exhibit a greater AH and AV than sites that received DBBM
only, which might be attributable to the additional grafted volume of the collagen. The differences,
however, were not statistically significant. The AH and AV in the DBBM/C/BMP-2 group decreased
from two to eight weeks, while conversely, those in all four of the other groups increased over time.
Interestingly, coronally sectioned views of the DBBM/C/BMP-2 group specifically demonstrated
radiolucent zones within the augmented area, and these radiographic voids also decreased in size
between two and eight weeks.
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Figure  2.  Radiographic  analysis: micro‐computed  tomography  in  the  rabbit  sinus‐augmentation 
model.  (A)  Three‐dimensionally  reconstructed  views  of  the  augmented  sites  at  two weeks  and  
eight weeks (scale bar = 10 mm); (B) Representative coronal cross‐sectional images at two weeks and 
eight weeks (scale bar = 10 mm). Coronally sectioned views of the DBBM/C/BMP‐2 group specifically 
exhibited  radiolucent zones  (* yellow) within  the augmented area. These  radiographic voids also 
decreased between weeks 2 and 8. Radiographically measured  results demonstrated  that  the  two 
experimental groups that received rhBMP‐2 exhibited increased augmentation volume (AV; C) and 
augmentation height (AH; D) compared to the other three groups in which rhBMP‐2 was not applied 
(** p < 0.05). The AV was  significantly  larger  in both  rhBMP‐2‐applied groups  than  in  the DBBM 
group († p < 0.05). AH was measured linearly on the cross‐sectional images. Regardless of the healing 
period, AH was significantly greater in the rhBMP‐2‐applied groups than in the other three groups 
(** p < 0.05). AH  increased between weeks 2 and 8 in all groups except the DBBM/C/BMP‐2 group  
(*  p  <  0.05). DBBM,  deproteinized  bovine  bone mineral; C,  absorbable  collagen  sponge;  BMP‐2,  
bone morphogenetic protein‐2; HA, hydroxyapatite‐coated collagen. 
3.2.2. Histologic Analysis 
In histologic samples of the two‐week groups, NB could be observed all around the augmented 
area, especially around the grafted particles and nearby preexisting bone/Schneiderian membrane 
(Figure 3A). Remarkable new bone formation in the area near to the Schneiderian membrane was a 
representative  feature  of  both  experimental  groups;  DBBM/C/BMP‐2  and  DBBM/HA/BMP‐2. 
However, the overall proportions of NB in the total augmented area were comparable regardless of 
the grafted biomaterials or the use of rhBMP‐2 (Table 1). 
Figure 2. Radiographic analysis: micro-computed tomography in the rabbit sinus-augmentation
model. (A) Three-dimensionally reconstructed views of the augmented sites at two weeks and eight
weeks (scale bar = 10 mm); (B) Representative coronal cross-sectional images at two weeks and eight
weeks (scale bar = 10 mm). Coronally sectioned views of the DBBM/C/BMP-2 group specifically
exhibited radiolucent zones (* yellow) within the augmented area. These radiographic voids also
decreased between weeks 2 and 8. Radiographically measured results demonstrated that the two
experimental groups that received rhBMP-2 exhibited increased augmentation volume (AV; C) and
augmentation height (AH; D) comp red to the other th ee groups in which rhBMP-2 was not applied
(** p < 0.05). The AV was ignificantly l ger in both rhBMP-2-applied groups than in the DBBM
group (: p < 0.05). AH was measured linearly on the cross-sectional images. Regardless of the healing
period, AH was significantly greater in the rhBMP-2-applied groups than in the other three groups
(** p < 0.05). AH increased between weeks 2 and 8 in all groups except the DBBM/C/BMP-2 group
(* p < 0.05). DBBM, deproteinized bovine bone mineral; C, absorbable collagen sponge; BMP-2, bone
morphogenetic protein-2; HA, hydroxyapatite-coated collagen.
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3.2.2. Histologic Analysis
In histologic samples of the two-week groups, NB could be observed all around the augmented
area, especially around the grafted particles and nearby preexisting bone/Schneiderian membrane
(Figure 3A). Remarkable new bone formation in the area near to the Schneiderian membrane was
a representative feature of both experimental groups; DBBM/C/BMP-2 and DBBM/HA/BMP-2.
However, the overall proportions of NB in the total augmented area were comparable regardless
of the grafted biomaterials or the use of rhBMP-2 (Table 1).
Table 1. Histomorphometric results in sinus-augmentation model: proportion of composition in the
total augmented area (mean ˘ SD values).
Group
DBBM DBBM/C DBBM/C/BMP-2 DBBM/H DBBM/H/BMP-2
2
weeks
8
weeks
2
weeks
8
weeks
2
weeks
8
weeks
2
weeks
8
weeks
2
weeks
8
weeks
NB (%) 10.42 ˘0.43
25.29 ˘
4.16 *
10.58 ˘
2.30
24.87 ˘
4.69 *
12.09 ˘
2.14
28.42 ˘
2.51 *
10.97 ˘
2.04
23.01 ˘
3.50 *
13.29 ˘
6.02
30.80 ˘
5.43 *
RM (%) 29.10 ˘4.33
19.71 ˘
3.89
17.52 ˘
2.01
16.09 ˘
3.01
13.27 ˘
2.32
13.95 ˘
3.13
18.68 ˘
2.90
15.83 ˘
3.63
15.26 ˘
0.39
11.63 ˘
1.05
AT (%) 0.15 ˘0.08
0.65 ˘
0.61
0.18 ˘
0.06
1.55 ˘
1.00
0.12 ˘
0.02
12.92 ˘
2.91 *:
0.21 ˘
0.10
1.88 ˘
0.92
0.11 ˘
0.03
5.96 ˘
2.05 *#
BV (%) 1.37 ˘0.54
2.42 ˘
1.04
1.45 ˘
0.53
3.04 ˘
1.30
6.26 ˘
1.73 *:
2.83 ˘
0.50
1.34 ˘
0.48
3.10 ˘
1.58
3.87 ˘
0.77 :
2.48 ˘
0.50
CT (%) 58.96 ˘4.15
51.93 ˘
7.17
70.28 ˘
3.04
54.46 ˘
4.11
68.25 ˘
3.63 *#
41.88 ˘
5.22
68.80 ˘
3.86
56.19 ˘
2.71
67.47 ˘
6.29 #
49.13 ˘
9.00
* Significantly different between 2 and 8 weeks (p < 0.05); : Significantly different from BMP-2 untreated group
(p < 0.05); # Significantly different from DBBMgroup (p < 0.05); § Significantly different from DBBM/H/BMP-2
group (p < 0.05); NB, new formed bone; RM, residual material; AT, adipose tissue; BV, blood vessel; CT,
connective tissue.
Another peculiar healing pattern was observed at both experimental sites that were grafted with
ErhBMP-2—A very large amount of BV was formed in spaces between the particles (Figure 3B,C).
This feature was not found in the other three groups (i.e., DBBM, DBBM/C and DBBM/HA).
Histomorphometrically, both sites received ErhBMP-2 exhibited a statistically significant increase in
proportion of BV compared to the other three groups at 2 weeks, and it was significantly higher
in the DBBM/C/BMP-2 group than in the DBBM/HA/BMP-2 group (Table 1). However, this
pattern was decreased in all samples of both groups at eight weeks. Instead, another specific
feature within the grafted area of both samples that received ErhBMP-2 was a significantly increased
amount of AT formation, although samples of the other three groups exhibited dense CT (Figure 4).
DBBM/C/BMP-2 sites showed significantly greater AT formation than DBBM/HA/BMP-2. NB was
evenly distributed in all experimental/control grafted areas, and appeared as a more mature type
with increased lamellar bone compared to the sites of the two-week groups (Table 1).
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Another peculiar healing pattern was observed at both  experimental  sites  that were grafted 
with  ErhBMP‐2—A  very  large  amount  of  BV  was  formed  in  spaces  between  the  particles  
(Figure  3B,C).  This  feature was  not  found  in  the  other  three  groups  (i.e., DBBM, DBBM/C  and 
DBBM/HA). Histomorphometrically, both sites  received ErhBMP‐2 exhibited a statistically significant 
increase in proportion of BV compared to the other three groups at 2 weeks, and it was significantly 
higher in the DBBM/C/BMP‐2 group than in the DBBM/HA/BMP‐2 group (Table 1). However, this 
pattern was decreased in all samples of both groups at eight weeks. Instead, another specific feature 
within  the  grafted  area  of  both  samples  that  received  ErhBMP‐2 was  a  significantly  increased 
amount of AT formation, although samples of the other three groups exhibited dense CT (Figure 4). 
DBBM/C/BMP‐2 sites showed significantly greater AT  formation  than DBBM/HA/BMP‐2. NB was 
evenly distributed  in all experimental/control grafted areas, and appeared as a more mature  type 
with increased lamellar bone compared to the sites of the two‐week groups (Table 1). 
 
Figure 3. Histologic analysis in the rabbit sinus‐augmentation model at the two‐week healing point.  
(A) Low‐magnification image of the entire sinus‐augmentation site in each group after two weeks of 
healing  (Masson’s  trichrome  staining, original magnification ×40,  scale bar = 5 mm). Arrowheads 
indicate surgically created window sites. Newly formed bone (NB) could be observed all around the 
augmented  area,  but  was  concentrated  locally  around  the  grafted  particles  and  near  to  the 
preexisting  bone/Schneiderian membrane;  (B)  Representative  high‐magnification  view  (Masson’s 
trichrome staining, original magnification ×100, scale bar = 200 μm). (C) A twofold‐enlarged images 
in the center of (B) (Masson’s trichrome staining, magnification, ×200, scale bar = 100 μm). A peculiar 
healing pattern was observed at both experimental sites in which rhBMP‐2 was grafted; a very large 
amount of blood vessel  (BV)  formation  can be  seen  in all areas between  the particles and  it was 
significantly higher in the DBBM/C/BMP‐2 group than in the DBBM/HA/BMP‐2 group. Arrowheads, 
surgically  created  entrance  of  window  opening;  DBBM,  deproteinized  bovine  bone  mineral;  
C, absorbable collagen sponge; BMP‐2, bone morphogenetic protein‐2; HA, hydroxyapatite‐coated 
collagen; RM, residual material; AT, adipose tissue; CT, connective tissue. 
. - - .
- fi f the entire sinus-augmentation site in each group after two weeks
of healing (Masson’s trichrome staining, original magnification ˆ40, scale bar = 5
i i sites. Newly formed bone (NB) could be obs rved ll around
the augmented area, but was concen rated locally around the grafted particles and ear
i ti i i ( ) - fi
original magn fication ˆ100, scale bar = 200 µm). (C) A twofold-enlarged
mag s i the center of (B) (Masson’s trichrome staining, magnification, ˆ200, scale bar = 100 µm).
A peculiar h aling pattern was o served at both experimental sites in which rhBMP-2 was grafted;
very large amount of blood vessel (BV) formation can be seen in all areas between the particle
and it was significa tly higher in the DBBM/C/BMP-2 group than in the DBBM/HA/BMP-2
group. Arrowheads, surgically created entra ce of window pe ing; DBBM, deprotei ized
bovine bone mineral; C, absorbable collagen sponge; BMP-2, bone morphogenetic protein-2; HA,
hydroxyapatite-coated collagen; RM, residual material; AT, adipose tissue; CT, connective tissue.
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Figure 4. Histologic analysis in the rabbit sinus‐augmentation model at the eight‐week healing point. 
(A) Low‐magnification image of the entire sinus‐augmentation site in each groups after eight weeks 
of healing (Masson’s trichrome staining, original magnification ×40, scale bar = 5 mm). Newly formed 
bone (NB) was evenly distributed at all of the grafted area regardless of the experimental group, and 
appeared as a more mature type with increased lamellar bone compared to the sites in the two‐week 
groups;  (B)  Representative  high‐magnification  view  (Masson’s  trichrome  staining,  original 
magnification ×100, scale bar = 200μm); (C) A twofold‐enlarged image in the center of (B) (Masson’s 
trichrome staining, magnification ×200, scale bar = 100μm). There was a very large amount of adipose 
tissue  (AT)  formation within  the grafted area  in both  samples  that  received  rhBMP‐2, and  it was 
significantly higher in the DBBM/C/BMP‐2 group than in the DBBM/HA/BMP‐2 group. Samples of 
the  other  three  groups  showed  dense  connective  tissues  (CT)  in  the  area  between  the  residual 
material (RM) and NB. Reduction of AT formation when using an HA‐coated collagen as a carrier for 
BMP‐2  enhances  the  bone  quality. Arrowheads,  surgically  created  entrance  of window  opening; 
DBBM,  deproteinized  bovine  bone  mineral;  C,  absorbable  collagen  sponge;  BMP‐2,  bone 
morphogenetic protein‐2; HA, hydroxyapatite‐coated collagen; BV, blood vessel. 
3.3. In Vivo Tissue Regeneration in the Dog Extraction‐Socket Model 
3.3.1. Radiographic Analysis 
Alveolar ridge resorption following tooth extraction was observed in all groups, and was more 
pronounced  in  buccal  and  coronal  regions  than  in  the  lingual  and  apical  regions  (Figure  5A). 
However,  the  reduction  of  the  alveolar  bone  area  and  height  in  the  fresh  extraction  socket was 
significantly  decreased  in  all  of  the  grafted  groups  compared  to  the  control  group  (Figure  5C).  
In  addition, dimensional  alterations  of  alveolar  ridge  in DBBM/C/BMP‐2  and DBBM/HA/BMP‐2 
groups were also significantly less than in the other grafted extraction‐socket groups (i.e., the DBBM, 
DBBM/C and DBBM/HA groups) (Figure 5D). 
Figure 4. Histologic analysis in the rabbit sinus-augmentation model at the eight-week healing
point. (A) Low-magnification image of the entire sinus-augmentation site in each groups after
eight weeks of healing (Masson’s trichrome staining, original magnification ˆ40, scale bar = 5 mm).
Newly formed bone (NB) was evenly distributed at all of the grafted area regardless of the
experimental group, and appeared as a more mature type with increased lamellar bone compared to
the sites in the two-week groups; (B) Representative high-magnification view (Masson’s trichrome
staining, original magnification ˆ100, scale bar = 200µm); (C) A twofold-enlarged image in the
center of (B) (Masson’s trichrome staining, magnification ˆ200, scale bar = 100µm). There was
a very large amount of adipose tissue (AT) formation within the grafted area in both samples
that received rhBMP-2, and it was significantly higher in the DBBM/C/BMP-2 group than in the
DBBM/HA/BMP-2 group. Samples of the other three groups showed dense connective tissues (CT)
in the area between the residual material (RM) and NB. Reduction of AT formation when using an
HA-coated collagen as a carrier for BMP-2 enhances the bone quality. Arrowheads, surgically created
entrance of window opening; DBBM, deproteinized bovine bone mineral; C, absorbable collagen
sponge; BMP-2, bone morphogenetic protein-2; HA, hydroxyapatite-coated collagen; BV, blood vessel.
3.3. In Vivo Tissue Regeneration in the Dog Extraction-Socket Model
3.3.1. Radiographic nalysis
lveolar ridge resorption following tooth extraction was observed in all groups, and was
more pronounced in buccal and coronal regions than in the lingual and apical regions (Figure 5 ).
o ever, the reduction of the alveolar bone area and height in the fresh extraction socket as
significantly decreased in all of the grafted groups co pared to the control group (Figure 5C).
In addition, di ensional alterations of alveolar ridge in DBBM/C/B P-2 and DBBM/ /B P-2
groups ere also significantly less than in the other grafted extraction-socket groups (i.e., the DBB ,
DBB /C and DBB /HA groups) (Figure 5D).
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Figure 5. Radiographic analysis: micro‐computed tomography of the beagle extraction‐socket model. 
(A)  Buccolingual  cross‐sectional  view  of  the  augmented  sites  after  eight  weeks  of  healing  
(scale bar = 5mm). The alveolar ridge resorption was more pronounced  in  the buccal and coronal 
regions than in the lingual and apical regions; (B) Schematic indicating the locations of the various 
measurements,  using  superimposing  central‐most  sagittal  views  of  experimental  site  (extracted 
and/or grafted) and pristine  tooth site at  the contralateral mandible;  (C) The reduction of alveolar 
bone height  in  the  fresh extraction socket was significantly decreased  in all of  the grafted groups 
compared to the control group (* p < 0.05). Two augmentation sites that received rhBMP‐2 showed a 
significantly decreased vertical distance  compared  to  the other  three grafted groups  (** p < 0.05);  
(D) All grafted groups showed decreases  in  the reduction of  the alveolar bone area compared  to  the 
control group  (* p < 0.05). These dimensional  reductions of  the alveolar  ridge at sites  that  received 
rhBMP‐2  were  also  significantly  decreased  than  in  the  other  grafted  extraction‐socket  groups  
(**, significantly different from groups not treated with rhBMP‐2; †, significantly different from the 
DBBM  and DBBM/C groups). DBBM, deproteinized bovine bone mineral; C,  absorbable  collagen 
sponge; BMP‐2, bone morphogenetic protein‐2; HA, hydroxyapatite‐coated collagen. 
3.3.2. Histologic Analysis 
All sites healed with buccal bone plate resorption, but the histologic amounts of dimensional 
alteration differed between the groups according to the graft materials used. Alveolar bone area in 
coronal  half  of  the  dental  root  length  at  control  sites  was  significantly  lower  than  the  other 
experimental sites (Figure 6A). However, the DBBM/C/BMP‐2 and DBBM/HA/BMP‐2 sites exhibited 
significantly higher proportions of adipose bone marrow tissue compared to the other three grafted 
sites (i.e., the DBBM, DBBM/C and DBBM/HA), in which dense CT could be found instead of adipose 
bone marrow tissue (Figure 6B,C). Interestingly, DBBM/C/BMP‐2 group had a significantly higher 
proportion of adipose bone marrow tissue than the DBBM/HA/BMP‐2 group, even though there were 
similar proportions of that tissue in DBBM/C and DBBM/HA groups (Table 2). 
5. Radiographic analysis: micro-computed tomography of the beagle extraction-socket
model. (A) Buccolingual cross-sectional view of the augmented ites after eight w eks of
r = 5 ). The alveolar ri ge res r tio s i
i t i t li l i l i ; ti i i ti t l ti t i
r t , i ri i tr l- t itt l i f ri t l it ( tr t
or grafted) and risti e to t sit t t tr l t r l i l ; ( ) r ti f l l r
e ei t i t e fres extracti s c et as si ifica tl ecrease i all f t e rafte r s
co are to the control gro (* p < 0.05). Two augmentation sites that received rhBMP-2 showed
a significantly decreased vertical distance compared to the other three grafted groups (** p < 0.05);
( ) ll grafted groups sho ed decreases in the reduction of the alveolar bone area compared to
the control group (* p < 0.05). These dimensional reductions of the alveolar ridge at sites that
received rhBMP-2 were also significantly decreased than in the other grafted extraction-socket groups
(**, significantly different from groups not treated with rhBMP-2; :, significantly different from the
DBBM and DBBM/C groups). DBBM, deproteinized bovine bone mineral; C, absorbable collagen
sponge; BMP-2, bone morphogenetic protein-2; HA, hydroxyapatite-coated collagen.
. . . i t l i l i
ll it l it l l t ti , t t i t l i t f i i l
lt ti iffere betw en the groups according to the graft m terials used. Alveolar bone
area in coronal half of the dental root length at control site was significantly lower than the
other experimental sites (Figure 6A). However, the DB /C/BMP-2 and DB /HA/BMP-2 sites
exhibited significantly higher proportions of adipose b ne marrow tissue compared to the other thr e
grafted si es (i.e., the , DBBM/C and DBBM/HA), in which dense CT c ld be found instead of
adipose bone marrow tissu (Figure 6B,C). I terestingly, DB /C/BMP-2 group had a significantly
higher proportion f adipose bone marrow tissue than the DB /HA/BMP-2 group, even though
there we e similar proportions of that tissue i DBBM/C and DBBM/HA groups (Table 2).
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Figure 6. Histologic analysis of the beagle extraction‐socket model. (A) Low‐magnification image of 
the extraction site after eight weeks of healing (Masson’s trichrome staining, original magnification 
×40, scale bar = 5 mm). While control sites showed a significant decrease in alveolar bone width at the 
coronal half of  the dental  root  length, buccal bone plates at  the other  five grafted  sites were  in a 
higher position  than at  the control site;  (B) Representative high‐magnification view of  the coronal 
region  of  the  augmented  area  (Masson’s  trichrome  staining,  original  magnification  ×100,  
scale bar = 400 μm); (C) A twofold‐enlarged image in the center of (B) (Masson’s trichrome staining, 
magnification ×200, scale bar = 200 μm). Sites that received rhBMP‐2 appeared to be in a more mature 
healing phase and showed higher proportions of adipose bone marrow tissue compared to the other 
three grafted sites, in which dense connective tissue could be found instead of adipose bone marrow 
tissue. DBBM,  deproteinized  bovine  bone mineral;  C,  absorbable  collagen  sponge;  BMP‐2,  bone 
morphogenetic  protein‐2;  HA,  hydroxyapatite‐coated  collagen;  NB,  newly  formed  bone;  
RM, residual material; AT, adipose tissue; BV, blood vessel; CT, connective tissue. 
Table 2. Histomorphometric results in extraction‐socket grafting model: proportion of composition 
of the augmented area (mean ± SD values). 
Group  Control DBBM  DBBM/C DBBM/C/BMP‐2 DBBM/H DBBM/H/BMP‐2 
NB (%)  39.72 ± 12.85  31.58 ±5.92  28.44 ± 8.37  42.26 ± 8.46  26.11 ± 4.93  52.92 ± 7.33 † 
RM (%)  0.00  19.78 ± 3.50  20.22 ± 8.13  8.96 ± 3.93 †  17.73 ± 5.81  4.71 ± 1.19 † 
AT (%)  26.07 ± 8.08 †  10.19 ± 1.20  12.27 ± 0.88  27.20 ± 8.43 †§  12.70 ± 2.31  16.16 ± 6.12 † 
BV (%)  6.88 ± 2.43 †§  2.74 ± 1.07  1.60 ± 0.91  4.46 ± 1.24  3.24 ± 0.59  3.61 ± 2.04 
CT (%)  27.33 ± 5.69  35.71 ± 8.99  37.47 ± 8.86  17.13 ± 5.61 †  40.23 ± 6.68 #§  22.60 ± 6.29 † 
†  Significantly  diﬀerent  from  BMP‐2  untreated  group  (p  <  0.05);  #  Significantly  different  from 
DBBM/C/BMP‐2group (p < 0.05); § Significantly different from DBBM/H/BMP‐2 group (p < 0.05); NB, new formed 
bone; RM, residual material; AT, adipose tissue; BV, blood vessel; CT, connective tissue. 
4. Discussion 
This study was based on the hypothesis that HA‐coating on collagen carrier would  influence 
the direction of cellular differentiation due to its feature of controlled‐release of rhBMP‐2. Therefore, 
two types of cellular differentiation (osteogenic and adipogenic differentiation) were included in the 
in vitro  test, because  these are  the  representative decisive  factors  for bone quality.  In  the present 
study, cells grown in medium to which ErhBMP‐2 was added directly exhibited the highest level of 
both osteogenic and adipogenic differentiation. However, cells in C/BMP‐2 and HA/BMP‐2 groups 
Figure 6. Histologic analysis of the beagle extraction-socket model. (A) Low-magnification
image of the extraction site after eight weeks of healing (Masson’s trichrome staining, original
magnification ˆ40, scale bar = 5 mm). While control sites showed a significant decrease in alveolar
bone width at the coronal half of the dental root length, buccal bone plates at the other five grafted
sites were in a higher position than at the control site; (B) Representative high-magnification view of
the coronal region of the augmented area (Masson’s trichrome staining, original magnification ˆ100,
scale bar = 400 µm); (C) A twofold-enlarged image in the center of (B) (Masson’s trichrome staining,
magnification ˆ200, scale bar = 200 µm). Sites that received rhBMP-2 appeared to be in a more
mature healing phase and showed higher proportions of adipose bone marrow tissue compared to
the other three grafted sites, in which dense connective tissue could be found instead of adipose bone
marrow tissue. DBBM, deproteinized bovine bone mineral; C, absorbable collagen sponge; BMP-2,
bone morphogenetic protein-2; HA, hydroxyapatite-coated collagen; NB, newly formed bone; RM,
residual material; AT, adipose tissue; BV, blood vessel; CT, connective tissue.
Table 2. Histomorphometric results in extraction-socket grafting model: proportion of composition
of the augmented area (mean ˘ SD values).
Group Control DBBM DBBM/C DBBM/C/BMP-2 DBBM/H DBBM/H/BMP-2
NB (%) 39.72 ˘ 12.85 31.58 ˘5.92 28.44 ˘ 8.37 42.26 ˘ 8.46 26.11 ˘ 4.93 52.92 ˘ 7.33 :
RM (%) 0.00 19.78 ˘ 3.50 20.22 ˘ 8.13 8.96 ˘ 3.93 : 17.73 ˘ 5.81 4.71 ˘ 1.19 :
AT (%) 26.07 ˘ 8.08 : 10.19 ˘ 1.20 12.27 ˘ 0.88 27.20 ˘ 8.43 : 12.70 ˘ 2.31 16.16 ˘ 6.12 :
BV (%) 6.88 ˘ 2.43 : 2 4 ˘ 1.07 1.60 ˘ 0.91 4.46 ˘ 1.24 3.24 ˘ 0.59 3. 1 ˘ 2.04
CT (%) 27.33 ˘ 5.69 35.71 ˘ 8.99 37.47 ˘ 8.86 17.13 ˘ 5.61 : 40.23 ˘ 6.68 #§ 22.60 ˘ 6.29 :
: Significantly different from BMP-2 untreated group (p < 0.05); # Significantly different fro
DBBM/C/BMP-2group (p < 0.05); § Significantly different from DBBM/H/BMP-2 group (p < 0.05); NB, new
formed bone; RM, residual material; AT, adipose tissue; BV, blood vessel; CT, connective tissue.
4. Discussion
This study was based on the hypothesis that HA-coating on collagen carrier would influence
the direction of cellular differentiation due to its feature of controlled-release of rhBMP-2. Therefore,
two types of cellular differentiation (osteogenic and adipogenic differentiation) were included in the
in vitro test, because these are the representative decisive factors for bone quality. In the present
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study, cells grown in medium to which ErhBMP-2 was added directly exhibited the highest level
of both osteogenic and adipogenic differentiation. However, cells in C/BMP-2 and HA/BMP-2
groups demonstrated significantly reduced formation of mineralized nodules and lipid vacuoles, and
especially cells in the HA/BMP-2 group, which had the significantly lowest values of osteogenesis
and adipogenesis in the initial release period (which was 3 days in this study). HA-coating onto
ACS reduced initial burst release of rhBMP-2, and showed controlled profile of rhBMP-2 release
with the increase of the proportion of HA coating in our previous study: [14] 98% and 40% of
the loaded rhBMP-2 were released from the collagen and HA-coated collagen for 3 days. In
addition, another one of our previous studies showed that controlled release of rhBMP-2 reduced
adipose tissue formation of unwanted tissue response by rhBMP-2 and enhanced bone quality [11].
Many previous studies reported clinically negative effects of rhBMP-2 on bone density by adipose
tissue formation [9–12], and the present results also demonstrated formation of rhBMP-2-specific
tissues (vessels and adipose tissue) in sites that received ErhBMP-2. Osteogenesis and adipogenesis
gradually increased with increase of preincubation time in both experimental releasing groups.
These are in accordance with many previous studies showing increased cellular differentiation
with increased concentrations of rhBMP-2 [17,18], and decreased in vivo AT formation by other
controlled-releasing carrier systems [19,20].
A particularly interesting finding in this result was that the controlled release of rhBMP-2
reduced adipogenic differentiation significantly more than osteogenic differentiation (Figure 1).
Reduction in release of ErhBMP-2 may affect adipose formation more than mineralized tissue
formation at the in vitro level, suggesting that control of the initial burst release from the carrier
might reduce AT formation and enhance bone density. These findings are consistent with the
present in vivo experimental results and the results from previous studies [12]. The reduction in
the initial burst concentration by controlled-releasing carrier systems was shown to enhance bone
density and reduce AT formation [11]; on the other hand, the increase in rhBMP-2 concentration
induced seroma formation [21,22] or cystic changes [12,23]. Although adipogenic and osteogenic
differentiation by BMP-2 are dependent upon different binding receptors and target molecules, it is
interesting to note that two types of BMP pathway share the same downstream signaling events: the
Smad and p38 mitogen-activated protein kinase (MAPK) pathways. These in vitro and in vivo results
suggest that a high concentration of rhBMP-2 move those biologic pathways toward adipogenic
differentiation, although little is known about that mechanism.
The present in vivo results for the augmented sinus also revealed a peculiar healing pattern
at two weeks after surgery: the overwhelming formation of newly formed vessels despite limited
sources for angiogenesis. This feature has not been reported for any defect or ectopic models in vivo.
The sinus-augmentation model is a type of contained defect that is surrounded by limited healing
sources (e.g., the Schneiderian membrane) that contain minimal cells and glandular tissues. This
environment could have provided a low-oxygen state within the grafted area filled with biomaterials
and blood coagulum in the early healing phase. This hypoxic state might regulate the ErhBMP-2
activity from the undifferentiated to endothelial cells [24]. However, this particular healing pattern
had disappeared at 8 weeks, and increased AT formation could be observed at both experimental
sites that received rhBMP-2 compared to all non-rhBMP-2 sites, which were filled with fibrovascular
connective tissues instead of AT. However, these specific tissues (BV and AT in the early and late
healing phase, respectively) were significantly reduced in the sinuses of DBBM/HA/BMP-2, which
could be supported by the present in vitro results. However, the underlying mechanism and the
relationship between angiogenesis and adipogenesis require further study.
An enhanced bone density (and reduced AT formation) of the regenerated tissue was also
observed in the extraction-socket model that received rhBMP-2-loaded HA-coated collagen. In
addition, osteoinductive activity of ErhBMP-2 could decrease the buccolingual shrinkage of the
alveolar ridge following tooth extraction. Many preclinical and clinical studies have found significant
alteration of the alveolar ridge dimensions in the coronal area of the extraction socket [25,26].
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Araujö et al. found a 35% reduction in the buccolingual dimension of the coronal area after
extraction, but minimal alterations in both the middle and apical areas were noted [25]. However,
more vigorous reductions of the alveolar ridges in the coronal (58%) and middle (29%) areas
were observed in control sites of the present study. This finding may be attributable to the
difference between the experimental models used: Araujö et al. used a single root extraction
socket, while a multiple extraction-socket model was used in the present study. Interestingly, unlike
control sites, experimental sites that received ErhBMP-2—regardless of the carrier system—exhibited
well-maintained grafted biomaterials beyond the resorbed buccal bone level. Osteoinductivity by
rhBMP-2 might cause mineralized tissue formation in the area, as has already been shown in
other ectopic models [10,27–29]. Both quantitatively and qualitatively, ErhBMP-2-loaded HA-coated
collagen may be beneficial for extraction-socket treatment, even at sites with multiple extractions.
This may be produced by enhancement of bone formation rather than bone remodeling via osteoclast
activation; however, further study is needed to confirm this suggestion.
While two contained-types of in vivo models were used in the present study (the
sinus-augmentation and extraction-socket models), there are some differences between them;
including the types of cells present, the relative abundance (or lack there of) of healing sources, and
the clinical goal of treatment. Researchers and clinicians would expect the application of BMP-2 to
accelerate the bone healing processes in the sinus-augmentation model and reduce the healing period,
and reduce the dimensional alterations of alveolar ridge in the extraction-socket model. Therefore,
different observational periods and measurement parameters were used discriminately in each
model. In the grafted sinuses, a peculiar healing pattern and inferior bone density was observed in the
early healing period, and ErhBMP-2 failed to shorten healing time despite reduction of complication
by HA-coated collagen. However, the extraction socket healed with bony augmentation at sites that
received ErhBMP-2, and its dimensions were maintained. In addition, HA-coated collagen carriers
enhanced bone regeneration qualitatively and quantitatively in the socket model.
5. Conclusions
In conclusion, HA-coated collagen carriers for ErhBMP-2 may reduce in vitro induction
of adipogenic differentiation and in vivo adipose bone marrow tissue formation in bone tissue
engineering by ErhBMP-2. These results suggest that HA-coated collagen carrier systems loaded
with ErhBMP-2 may reduce adipose tissue formation, and can ultimately be expected to enhance
clinical bone quality in rhBMP-2-engineered tissues. ErhBMP-2 failed to accelerate the bone-healing
processes in the sinus-augmentation model, despite the use of HA-coated collagen as a carrier.
However, rhBMP-2-loaded HA-coated collagen could be a candidate for extraction-socket therapy,
as evidenced by the quantitative and qualitative enhancement of bone regeneration in the
socket-grafting model.
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